Non-viral delivery of the CRISPR/Cas system: DNAversusRNAversusRNP
genome editing in patients has not been reached so far. The article summarises the characteristics and differences of each format, provides an overview of the published delivery strategies and highlights recent examples of delivery systems including the status of clinical applications.
